Jerasimos Ballas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jerasimos Ballas has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
- Dora J. Melber
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, California
3 shared publications - Carla Marienfeld
Department of Psychiatry, University of California San Diego, San Diego, USA
2 shared publications - Christina D. Chambers
Department of Pediatrics University of California San Diego La Jolla California USA
2 shared publications - Gladys Ramos
Department of Obstetrics, Gynecology and Reproductive Medicine, University of California, San Diego, La Jolla, CA, USA
2 shared publications - Kathy Zhang-Rutledge
Obstetrix Maternal-Fetal Medicine Specialists of Houston, Houston, TX 77054, USA
2 shared publications - Laramie R. Smith
School of Medicine University of California San Diego La Jolla California USA
2 shared publications
Latest Publications
- Open Access
- 17 April 2026
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 8 (7) , 101968
Severe maternal morbidity and hypertensive disorders of pregnancy among women with intellectual disabilities: Identifying potential intervention targets
- 17 April 2026
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 8 (7) , 101968
Open AccessSevere maternal morbidity and hypertensive disorders of pregnancy among women with intellectual disabilities: Identifying potential intervention targets
- 30 July 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (11) , 1915-1921
Intraoperative Multivessel Embolization Reduces Blood Loss and Transfusion Requirements Compared to Internal Iliac Artery Balloon Placement during Cesarean Hysterectomy for Placenta Accreta Spectrum
- 30 July 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (11) , 1915-1921
Intraoperative Multivessel Embolization Reduces Blood Loss and Transfusion Requirements Compared to Internal Iliac Artery Balloon Placement during Cesarean Hysterectomy for Placenta Accreta Spectrum
- 28 June 2022
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 41 (2) , 137-148
Substance-related diagnosis type predicts the likelihood and co-occurrence of preterm and cesarean delivery
This article aimed to evaluate whether a substance-related diagnosis (SRD; i.e., alcohol, opioids, cannabis, stimulants, nicotine) predicts the likelihood and co-occurrence of preterm (20–37 weeks’...
- 28 June 2022
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 41 (2) , 137-148
Substance-related diagnosis type predicts the likelihood and co-occurrence of preterm and cesarean delivery
This article aimed to evaluate whether a substance-related diagnosis (SRD; i.e., alcohol, opioids, cannabis, stimulants, nicotine) predicts the likelihood and co-occurrence of preterm (20–37 weeks’...
- Open Access
- 1 October 2021
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 225 (4) , 442.e1-442.e10
Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol
- 1 October 2021
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 225 (4) , 442.e1-442.e10
Open AccessPlacenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol
- 2 August 2021
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 45 (9) , 1829-1839
Association of alcohol and other substance‐related diagnoses with severe maternal morbidity
Background: Pregnant women with a substance‐related diagnosis, such as an alcohol use disorder, are a vulnerable population that may experience higher rates of severe maternal morbidity, such as hemorrhage and eclampsia, than pregnant women with no substance‐related diagnosis.Methods: This retrospective cross‐sectional study reviewed electronic health record data on women (aged 18–44 years) who delivered a single live birth or stillbirth at ≥ 20 weeks of gestation from March 1, 2016, to August 30, 2019. Women with and without a substance‐related diagnosis were matched on key demographic characteristics, such as age, at a 1:1 ratio. Adjusting for these covariates, odds ratios and 95% confidence intervals were calculated.Results: A total of 10,125 deliveries met the eligibility criteria for this study. In the matched cohort of 1,346 deliveries, 673 (50.0%) had a substance‐related diagnosis, and 94 (7.0%) had severe maternal morbidity. The most common indicators in women with a substance‐related diagnosis included hysterectomy (17.7%), eclampsia (15.8%), air and thrombotic embolism (11.1%), and conversion of cardiac rhythm (11.1%). Having a substance‐related diagnosis was associated with severe maternal morbidity (adjusted odds ratio = 1.81 [95% CI, 1.14–2.88], p‐value = 0.0126). In the independent matched cohorts by substance type, an alcohol‐related diagnosis was significantly associated with severe maternal morbidity (adjusted odds ratio = 3.07 [95% CI, 1.58–5.95], p‐value = 0.0009), while the patterns for stimulant‐ and nicotine‐related diagnoses were not as well resolved with severe maternal morbidity and opioid‐ and cannabis‐related diagnoses were not associated with severe maternal morbidity.Conclusion: We found that an alcohol‐related diagnosis, although lowest in prevalence of the substance‐related diagnoses, had the highest odds of severe maternal morbidity of any substance‐related diagnosis assessed in this study. These findings reinforce the need to identify alcohol‐related diagnoses in pregnant women early to minimize potential harm through intervention and treatment.
- 2 August 2021
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 45 (9) , 1829-1839
Association of alcohol and other substance‐related diagnoses with severe maternal morbidity
Background: Pregnant women with a substance‐related diagnosis, such as an alcohol use disorder, are a vulnerable population that may experience higher rates of severe maternal morbidity, such as hemorrhage and eclampsia, than pregnant women with no substance‐related diagnosis.Methods: This retrospective cross‐sectional study reviewed electronic health record data on women (aged 18–44 years) who delivered a single live birth or stillbirth at ≥ 20 weeks of gestation from March 1, 2016, to August 30, 2019. Women with and without a substance‐related diagnosis were matched on key demographic characteristics, such as age, at a 1:1 ratio. Adjusting for these covariates, odds ratios and 95% confidence intervals were calculated.Results: A total of 10,125 deliveries met the eligibility criteria for this study. In the matched cohort of 1,346 deliveries, 673 (50.0%) had a substance‐related diagnosis, and 94 (7.0%) had severe maternal morbidity. The most common indicators in women with a substance‐related diagnosis included hysterectomy (17.7%), eclampsia (15.8%), air and thrombotic embolism (11.1%), and conversion of cardiac rhythm (11.1%). Having a substance‐related diagnosis was associated with severe maternal morbidity (adjusted odds ratio = 1.81 [95% CI, 1.14–2.88], p‐value = 0.0126). In the independent matched cohorts by substance type, an alcohol‐related diagnosis was significantly associated with severe maternal morbidity (adjusted odds ratio = 3.07 [95% CI, 1.58–5.95], p‐value = 0.0009), while the patterns for stimulant‐ and nicotine‐related diagnoses were not as well resolved with severe maternal morbidity and opioid‐ and cannabis‐related diagnoses were not associated with severe maternal morbidity.Conclusion: We found that an alcohol‐related diagnosis, although lowest in prevalence of the substance‐related diagnoses, had the highest odds of severe maternal morbidity of any substance‐related diagnosis assessed in this study. These findings reinforce the need to identify alcohol‐related diagnoses in pregnant women early to minimize potential harm through intervention and treatment.
- 26 March 2021
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 41 (2) , 327-333
FundAl Retroflexion ( FAR ) angle is a novel sonographic marker associated with Cesarean scar pregnancies in the first trimester
Objectives Early diagnosis of Cesarean scar pregnancies (CSP) remains difficult. This study describes a novel sonographic marker, the FundAl Retroflexion (FAR) angle, that may be used in the first trimester. The objective of the study is to compare the FAR angle between CSP and normal pregnancies. Methods For this case–control study, we reviewed images from our institution's database that were acquired from January 2016 to December 2019. All cases of CSP and randomly selected controls, defined as patients with history of Cesarean delivery and normal implantation, that underwent ultrasound evaluation at P < 0.001). Using an ROC curve, a FAR angle cut off of 40° maximizes the ability to distinguish between CSP from normal pregnancies. Conclusions The FAR angle provides an easily obtainable and numerical measurement. CSP have larger FAR angle compared to normal controls with a distinguishing cut off of 40°. Larger studies are needed to determine if using the FAR angle can improve first trimester diagnosis for CSP.
- 26 March 2021
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 41 (2) , 327-333
FundAl Retroflexion ( FAR ) angle is a novel sonographic marker associated with Cesarean scar pregnancies in the first trimester
Objectives Early diagnosis of Cesarean scar pregnancies (CSP) remains difficult. This study describes a novel sonographic marker, the FundAl Retroflexion (FAR) angle, that may be used in the first trimester. The objective of the study is to compare the FAR angle between CSP and normal pregnancies. Methods For this case–control study, we reviewed images from our institution's database that were acquired from January 2016 to December 2019. All cases of CSP and randomly selected controls, defined as patients with history of Cesarean delivery and normal implantation, that underwent ultrasound evaluation at P < 0.001). Using an ROC curve, a FAR angle cut off of 40° maximizes the ability to distinguish between CSP from normal pregnancies. Conclusions The FAR angle provides an easily obtainable and numerical measurement. CSP have larger FAR angle compared to normal controls with a distinguishing cut off of 40°. Larger studies are needed to determine if using the FAR angle can improve first trimester diagnosis for CSP.
- 1 September 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 207 (3) , A1-A14
Table of Contents
- 1 September 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 207 (3) , A1-A14
Table of Contents